Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 12, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • Covid
  • Page 5

Tag: Covid

  • Biotechnopedia

Asymptomatic patients of COVID-19: threat to the population?

bioxone September 18, 2020September 18, 2020

-Anwesha Chatterjee, Amity University Kolkata The novel coronavirus is spreading rapidly throughout the world. It is impossible to restrict the spread of the SARS-CoV-2.  A huge proportion of the population across the world got infected and showed the most common to mild to serious symptoms (fever, dry cough, respiratory problems, conjunctivitis, aches, pains, rashes, and many more) along with the high […]

Read More
  • BiotechToday
  • World

JAGN1: A new soldier in the immune system

bioxone September 17, 2020September 17, 2020

–PRIYANKA CHAKRABORTY, AMITY UNIVERSITY KOLKATA The foundation for the quest in vaccine discovery lies in antibodies and its immune response. Immunoglobulins (minute proteins) are the sole defenders against invading pathogens. Therefore, the detailed study of the immune system is a fascination around the globe. Recently, Dr. Josef Penninger’s group at IMBA and UBC were amazed […]

Read More
  • BiotechToday
  • World

COVID UPDATE: Newly discovered tiny antibodies are completely defeating the menacing coronavirus

bioxone September 16, 2020September 16, 2020

-Binayak Das,Team bioXone A team of scientists has successfully isolated what they believe to be, as being the smallest biological molecule found till date, it being approximately one-tenth the size of an average antibody molecule. They have designed a therapeutic and pre-emptive drug called- Ab8 using it, which they propose will be able to not […]

Read More
  • BiotechToday
  • FEATURED
  • India
  • Latest
  • World

ARE TEMPERATURE CHECKS A GOOD WAY FOR ASSESSING COVID-19?

bioxone September 16, 2020September 16, 2020 16

– Husna, Amity University Kolkata Recently, as the world is implementing re-opening plans during the COVID-19 pandemic, infrared contact-free temperature assessment devices are being used at entry points to identify and screen out feverish individuals who may carry the coronavirus. But even when the devices are used properly, temperature assessment may have a limited impact […]

Read More
  • BiotechToday
  • FEATURED
  • India
  • Latest
  • World

COMPUTER DESIGNED SYNTHETIC ANTIVIRAL PROTEINS INHIBIT SARS-COV 2/COVID 19 IN HUMAN CELLS

bioxone September 15, 2020September 15, 2020

–Rishav Chakraborty, Calcutta National Medical College, Kolkata The SARS-COV infection occurred first in 2003-2004. The infection is believed to be contracted from animals including monkeys, Himalayan palm civets, cats, dogs, and rodents. Clinical manifestation including myalgia, headache, sore throat, and fever followed by severe respiratory distress. The virus binds with the ACE-2 (Angiotensinogen Converting Enzyme) […]

Read More
  • BiotechToday
  • FEATURED
  • World

Memories remaining clear and detailed even after encountering new experiences? Find out how

bioxone September 15, 2020September 15, 2020 2

–Prama Ghosh, Amity University Kolkata A study by the University of Bristol describes a newfound mechanism of learning in the brain which stabilizes memories and decreases impedance between them. Memories are created by excitatory connections between the nerve cells in the hypothalamus of the brain – a region crucial for the formation of memories. Inhibitory […]

Read More
  • BiotechToday
  • FEATURED
  • India
  • Latest

Are you resistant after recovery from Covid-19?

bioxone September 15, 2020September 14, 2020 2

-Mayukh Sinha, Amity University Kolkata The COVID-19 pandemic is the trending matter of concern. In addition to that, the post-recovery health of COVID-19 patients has imposed a threat as well. It has been reported that a 33-year-old Chinese man caught his second infection. It simply posed a doubt on the human immune system’s ability to […]

Read More
  • BiotechToday
  • FEATURED
  • Latest
  • World

COVID UPDATE: Coronavirus was fabricated in government-controlled Wuhan lab, claims Chinese virologist, Dr. Li-Meng Yan

bioxone September 14, 2020September 14, 2020 6

–Sagnik Nag, Amity University Kolkata The emergence of an exceedingly pathogenic human Coronavirus in the Middle East has sparked novel concern in human coronaviruses around the world. The coronavirus came into view in Wuhan, a city of 10.9 million people in China’s Hubei zone’19. The highly contagious novel SARS-COV-2 virus not only affected the medical […]

Read More
  • BiotechToday
  • FEATURED
  • Latest
  • World

Is self-quarantine a better idea?

bioxone September 13, 2020September 13, 2020

–Shrayana Ghosh, Amity University Kolkata A statement by the Centre for Disease Control and Prevention ( CDC) earlier stated that there was a comparatively higher risk of asymptomatic people being infected by COVID, which raised the number of people screened for COVID to a high level. Thousands of asymptomatic people flooded testing centers, resulting in […]

Read More
  • BiotechToday
  • FEATURED
  • Latest
  • World

Can one viral infection block the other?

bioxone September 13, 2020September 13, 2020 1

–Purbieta Nandy, Amity University Kolkata The Covid-19 pandemic has placed new urgency on examining the mechanisms influencing the spread of the virus. With each passing day, new techniques combating SARS-CoV-2 are coming up; One of those mechanisms is Viral Interference-phenomenon in which infection with one virus promotes resistance to other viruses. During the 2009 pandemic […]

Read More

Posts navigation

1 2 3 4 5 6 7

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy